Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019
Karen K. Giuliano, Dian Baker, Madhuli Thakkar‐Samtani, Michael Glick, Marcos I. Restrepo, Frank A. Scannapieco, Lisa J. Heaton, Julie Frantsve‐Hawley
Abstract
Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.
Topics & Concepts
MedicineMedicaidIncidence (geometry)PneumoniaEmergency medicineMortality rateDemographyPediatricsIntensive care medicineHealth careInternal medicineSociologyEconomicsOpticsPhysicsEconomic growthEmergency and Acute Care StudiesNosocomial Infections in ICUPneumonia and Respiratory Infections